The Europe autoimmune disease diagnostics market size is expected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the supportive government policies.
Autoimmune diseases are caused by an aberrant immune response in the body, which results in the development of antibodies that target the body's own cells and tissues, causing tissue degeneration and destruction. About 80 different forms of autoimmune disorders are discovered, including systemic lupus erythematosus and rheumatoid arthritis. According to the American Autoimmune Related Diseases Association (AARDA), autoimmune illness affects up to 50 million people in the US, with women accounting for more than 75% patients.
Market Trends, Drivers, Restraints, and Opportunities
- Improved laboratory methods and automation and increased public knowledge of autoimmune illnesses are driving the market expansion.
- Increasing prevalence of diseases such as rheumatoid arthritis, graves' disease, and hashimoto's disease is anticipated to boost the market growth.
- High frequency of false positive results can hamper the market growth.
Rapid technical breakthroughs in the medical area, such as innovative biomarkers, rising healthcare costs, increasing market expansion, and favorable government initiatives are expected to offer lucrative opportunities for the growth of the market.
Scope of the Report
The report on the Europe autoimmune disease diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Europe Autoimmune Disease Diagnostics Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Disease Types (Systemic Autoimmune Diseases [Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Multiple Sclerosis, and Others], and Localized Autoimmune Diseases [Inflammatory Bowel Disease, Thyroid, Type-1 Diabetes, and Others]), Diagnostic Techniques (Agglutination, Multiplex Immunoassay, Immunofluorescence Assays (IFA), Enzyme-linked Immunosorbent Assay (ELISA), Western Blotting, and Others)
|
|
Geographical Scope
|
Germany, France, The UK, Italy, Spain, and Rest of Europe
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
bioMérieux Inc.; Bio-Rad Laboratories Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; and Siemens Healthineers Inc.
|
Europe Autoimmune Disease Diagnostics Market Segment Insights
Systemic Autoimmune Diseases segment is projected to expand at a considerable CAGR
On the basis of disease types, the market is segregated into systemic autoimmune diseases and localized autoimmune disease. The systemic autoimmune disease segment is classified as rheumatoid arthritis, systemic lupus erythematosus (SLE), psoriasis, multiple sclerosis, and others. The localized autoimmune diseases segment is categorized as inflammatory bowel disease, thyroid, type-1 diabetes, and others. The Rheumatoid Arthritis sub-segment is projected to expand at a considerable CAGR during the forecast period due to rising awareness of rheumatoid arthritis and the availability of reimbursement plans in several nations.
Multiplex immunoassay segment is expected to grow at a rapid pace
Based on diagnostic techniques, the market is divided into agglutination, multiplex immunoassay, immunofluorescence assays (IFA), enzyme-linked immunosorbent assay (ELISA), western blotting, and others. The multiplex Immunoassay segment is expected to grow at a rapid pace during the forecast period owing to increasing public awareness and increased government funding aimed at improving healthcare infrastructure.
The UK is anticipated to constitute a key market share
In terms of regions, the Europe autoimmune disease diagnostics market is classified as Germany, France, the UK, Italy, Spain, and Rest of Europe. The UK is expected to constitute a key share of the market during the projected period due to availability of vast unexplored potential in emerging nations in the region. Moreover, in comparison to other parts of the autoimmune disease diagnosis, developed nations in Europe are expected to have a high incidence rate of autoimmune illnesses.
Segments
Segments Covered in the Report
The Europe autoimmune disease diagnostics market has been segmented on the basis of
Disease Types
- Systemic Autoimmune Diseases
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Psoriasis
- Multiple Sclerosis
- Others
- Localized Autoimmune Diseases
- Inflammatory Bowel Disease
- Thyroid
- Type-1 Diabetes
- Others
Diagnostic Techniques
- Agglutination
- Multiplex Immunoassay
- Immunofluorescence Assays (IFA)
- Enzyme-linked Immunosorbent Assay (ELISA)
- Western Blotting
- Others
Geography
- Germany
- France
- The UK
- Italy
- Spain
- Rest of Europe
Key Players
- bioMérieux Inc.
- Bio-Rad Laboratories Inc.
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Siemens Healthineers Inc.
Competitive Landscape
The Europe autoimmune disease diagnostics market is moderately competitive in nature. Bio-Rad Laboratories Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; and Siemens Healthineers Inc. However, several new firms are focused on market penetration, due to the rising market for autoimmune disease diagnostics in Europe.
Request For Customization
Enquiry Before Buying
Speak With Analyst
